ImmunologyScience ImmunologyPeer-reviewed
STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity
Jian Wang, Suxin Li, Maggie Wang…·Jinming Gao
A 'shock-and-lock' nanoparticle agonist activates STING in type 1 conventional dendritic cells to enhance antitumor immunity with associated biomarkers.